Psilocybin + Psychotherapy Cuts Heavy Drinking Days in Alcoholism
Percentage of heavy drinking days reduced with psilocybin combined with psychotherapy versus active placebo plus psychotherapy
Alcohol-Use Disorder
Genetically Targeted Therapeutic Looks Promising for Alcohol Use Disorder
AD04 is a genetically targeted, serotonin-3 receptor antagonist that is believed to reduce alcohol intake by interfering with the dopamine reward system.
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis
Off-Label Baclofen Use for Alcohol Use Disorders: Is it Effective?
Data showed a significant effect on abstinence rates with the use of baclofen (odds ratio [OR] 2.67, 95% CI: 1.03, 6.93) but no other significant effects on treatment efficacy (heavy drinking days SMD -0.26, 95% CI: -0.68, 0.15) or mechanism of action (craving SMD: -0.13, 95% CI: -0.36, 0.09) were seen.
Electrolyte Disturbances Common Among Patients with Alcohol-Use Disorder
Telltale signs of chronic alcohol use are large drops in plasma phosphate, magnesium, potassium, calcium
Imbibing Excessively Will Not Help Your Heart, Says New Study
Previous literature had suggested that moderate alcohol consumption may prevent heart attack and congestive heart failure.
Universal Alcohol Interlock Could Cut Many Crash Deaths/Injuries
Especially among young drivers; analysis shows device would be cost-effective in all new U.S. cars
Smoking, Drinking Prolong Gastrostomy Tube Requirement
Findings in patients with head and neck cancer undergoing prophylactic GT insertion
